Literature DB >> 21950943

Choosing optimal wavelength for photodynamic therapy of port wine stains by mathematic simulation.

Ying Wang1, Ying Gu, Zhaohui Zuo, Naiyan Huang.   

Abstract

Many laser wavelengths have been used in photodynamic therapy (PDT) for port wine stains (PWS). However, how these wavelengths result in different PDT outcomes has not been clearly illuminated. This study is designed to analyze which wavelengths would be the most advantageous for use in PDT for PWS. The singlet oxygen yield in PDT-treated PWS skin under different wavelengths at the same photosensitizer dosage was simulated and the following three situations were simulated and compared: 1. PDT efficiency of 488, 532, 510, 578, and 630 nm laser irradiation at clinical dosage (100 mW∕cm(2), 40 min); 2. PDT efficiency of different wavelength for PWS with hyperpigmentation after previous PDT; 3. PDT efficiency of different wavelengths for PWS, in which only deeply located ectatic vessels remained. The results showed that singlet oxygen yield is the highest at 510 nm, it is similar at 532 nm and 488 nm, and very low at 578 nm and 630 nm. This result is identical to the state in clinic. According to this theoretical study, the optimal wavelength for PDT in the treatment of PWS should near the absorption peaks of photosensitizer and where absorption from native chromophores (haemoglobin and melanin) is diminished.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21950943     DOI: 10.1117/1.3616127

Source DB:  PubMed          Journal:  J Biomed Opt        ISSN: 1083-3668            Impact factor:   3.170


  2 in total

Review 1.  Using Light for Therapy of Glioblastoma Multiforme (GBM).

Authors:  Alex Vasilev; Roba Sofi; Ruman Rahman; Stuart J Smith; Anja G Teschemacher; Sergey Kasparov
Journal:  Brain Sci       Date:  2020-01-31

2.  Hemoporfin Photodynamic Therapy for Port-Wine Stain: A Randomized Controlled Trial.

Authors:  Yi Zhao; Ping Tu; Guoyu Zhou; Zhanchao Zhou; Xiaoxi Lin; Huilan Yang; Zhong Lu; Tianwen Gao; Yating Tu; Hongfu Xie; Qingshan Zheng; Ying Gu; Jining Tao; Xuejun Zhu
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.